Skip to the page

Data / Form D filings / Savran Technologies Inc.

Savran Technologies Inc.: Form D filings

Savran Technologies Inc., a biotechnology company in Newton, MA, filed 6 Form D notices with the SEC between 2018 and 2024. The latest, on September 3, 2024, reports $424,696 sold of a $2 million offering to 30 investors.

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

Company details from the filing

Address
90 BRIDGE STREET, Newton, MA, 02458
Phone
(774) 245-5344
Industry
Biotechnology
Entity type
Corporation
Incorporated in
Delaware
Revenue range
Decline to Disclose
Exemptions claimed
Rule 506(b)
SEC identifier (CIK)
1732517

Form D filings

FiledTypeOfferingSoldRemainingInvestorsFirst saleFiling
Sep 3, 2024New notice$2,000,000$424,696$1,575,30430Aug 16, 2024sec.gov
Mar 7, 2023New noticeIndefinite$304,35018Feb 22, 2023sec.gov
Dec 14, 2021New notice$4,164,478$4,164,179$29952Dec 2, 2021sec.gov
May 19, 2020New notice$300,000$208,000$92,00011Mar 16, 2020sec.gov
Feb 27, 2019New notice$500,000$25,000$475,0001Sep 17, 2018sec.gov
Oct 22, 2018New notice$1,085,500$1,085,50029Jan 25, 2018sec.gov

Executive officers and directors named in the filing

NameRoleNote in the filing
Cagri SavranExecutive Officer, Director
Nadia AltomareDirector
Sal DaherDirector
Jeffrey BehrensDirector
Yavuz KaynarDirector

Other biotechnology companies in Massachusetts that filed recently

Every Form D from the week of Sep 2, 2024 · All recent filings in Massachusetts · All recent Biotechnology filings

Read from SEC EDGAR. Amount sold is what Savran Technologies Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.